Lars H. Jensen

Quantitative Proteomic Analysis of Post-translational Modifications of Human Histones

Hans Christian Beck, Eva C. Nielsen, Rune Matthiesen et al. · Molecular & Cellular Proteomics · 2006 · 197 citations · Full text

Histone Modifications, Epigenetic Change, Biological Mass Spectrometry +20

A Novel Mechanism of Cell Killing by Anti-topoisomerase II Bisdioxopiperazines

Lars H. Jensen, Karin C. Nitiss, Angela Rose et al. · Journal of Biological Chemistry · 2000 · 96 citations · Full text

Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy

Elke Martin, Annemette Thougaard, Morten Grauslund et al. · Toxicology · 2008 · 91 citations

Medicinal Chemistry, Heart Failure, Pharmacology +7

Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.

Maxwell Sehested, Irene Wessel, Lars H. Jensen et al. · PubMed · 1998 · 54 citations

Molecular Pharmacology, Drug Resistance Analysis, Chemoprevention Strategy +14

Maleimide Is a Potent Inhibitor of Topoisomerase II in Vitro and in Vivo: A New Mode of Catalytic Inhibition

Lars H. Jensen, Axelle Renodon‐Cornière, Irene Wessel et al. · Molecular Pharmacology · 2002 · 49 citations